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Abstract 
Cells sense and respond to mechanical cues from the extracellular matrix (ECM) via 
integrins. ECM stiffness is known to enhance integrin clustering and response to epidermal 
growth factor (EGF), but we lack information on when or if these mechanosensitive growth factor 
receptors and integrins converge intracellularly. Towards closing this knowledge gap, we 
combined a biomaterial platform with transcriptomics, molecular biology, and functional assays 
to link integrin-mediated mechanosensing and epidermal growth factor receptor (EGFR) 
signaling. We found that high integrin α6 expression controlled breast cancer cell adhesion and 
motility on soft, laminin-coated substrates, and this mimicked the response of cells to EGF 
stimulation. The mechanisms that drove both mechanosensitive cell adhesion and motility 
converged on calpain 2, an intracellular protease important for talin cleavage and focal adhesion 
turnover. EGF stimulation enhanced adhesion and motility on soft substrates, but required 
integrin α6 and calpain 2 signaling. In sum, we identified a new role for integrin α6 
mechanosensing in breast cancer, wherein cell adhesion to laminin on soft substrates mimicked 
EGF stimulation. We identified calpain 2, downstream of both integrin α6 engagement and EGFR 
phosphorylation, as a common intracellular signaling node, and implicate integrin α6 and calpain 
2 as potential targets to inhibit the migration of cancer cells in stiff tumor environments. 
 
 
Key Words: Biomaterials, Stiffness, Cell Motility, Poly(ethylene glycol), Extracellular Matrix, 
Laminin  
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Introduction 
Carcinoma progression is associated with deposition of ECM that stiffens the local 
microenvironment [1, 2]. This tissue stiffening results in deposition of additional matrix proteins, 
initiating a positive feedback loop between cells and the evolving stroma [3]. Cells sense and 
respond to the stiffness of their environment via RhoA GTPase activation, which feeds back to 
increase cell contractility via activation of myosin light chain kinase [4]. These ECM-driven 
changes in cytoskeletal tension regulate motility in a cell-type specific manner [5]. In vitro, 
synthetic biomaterials have revealed that the type of material, stiffness, and biochemical surface 
modification alter the attachment and motility of cells [6, 7]. We therefore hypothesized that 
independently tuning stiffness, while altering integrin-binding sites and the absence or presence of 
epidermal growth factor could reveal new mechanosensitive proteins that drive adhesion and 
motility in cancer cells.  
Several mechanically responsive genes and proteins have been implicated in breast cancer 
metastasis [8]. For example, extracellular mechanical forces in the tumor microenvironment alter 
nuclear stiffness and gene expression [9] and activate adhesion proteins, including focal adhesion 
kinase (FAK) and talin [10-12], leading to increased motility. One class of surface receptors, 
integrins, translate extracellular forces to downstream signaling cascades in a process called 
mechanotransduction. Increasing substrate stiffness increases integrin binding and clustering, 
which has implications for several pathways in breast cancer metastasis, including FAK and PI3K 
signaling [13, 14]. However, most cancer mechanobiology research has focused on collagen- and 
fibronectin-binding integrins. Integrins that bind to other ECM proteins,  including laminin 
investigated here, have largely been neglected, despite the prevalence of laminins, such as 
laminin-111 and -511, in the ECM of many tumor types, including breast and prostate cancers 
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[15-17]. In the breast cancer cell line, MDA-MB-231, laminin-511 enhances cell adhesion and 
migration [18], while laminin-322 promotes cell survival [19].  
EGFR has recently emerged as mechanosensitive [20, 21], and this process is critically 
relevant to cancer progression, given the known abundance of EGF in breast tumors [22] and 
frequent acquired resistance to EGFR inhibitors [23]. Residues on EGFR can be phosphorylated 
by αVβ3 integrin clustering [24], so we postulated that there could be a role for integrins in 
facilitating EGFR mechanosensing [25].  
To uncover whether such a relationship exists, we created a biomaterial system to identify 
mechanoresponsive proteins working cooperatively downstream of EGFR phosphorylation and 
laminin-binding integrin engagement in breast cancer. Through a combination of transcriptomics, 
molecular biology, and quantification of cell adhesion and motility, we found that the intracellular 
protease calpain 2 is one of these links.  Gene expression quantification revealed that both calpain 
2 and integrin α6 had an inverse relationship with ECM stiffness. Cell adhesion and motility 
experiments demonstrated that engagement of integrin α6 resulted in mechanosensitive effects on 
adhesion and motility in the same manner as EGF stimulation. This suggested coordination of 
integrin α6 with EGFR and that calpain 2 is downstream of both EGFR phosphorylation and 
integrin α6 engagement. Further, this indicated that calpain 2 is a common signaling node in the 
cell that regulates motility and cell adhesion in a mechanosensitive manner. In sum, we highlight 
the utility of tunable biomaterials systems to uncover previously unrealized relationships between 
different classes of proteins in breast cancer mechanobiology.  
 
Materials and Methods 
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Cell Culture. All cell culture reagents were purchased from Thermo Fisher Scientific 
(Waltham, MA) unless otherwise specified. MDA-MB-231 cells were a generous gift from Sallie 
Schneider at the Pioneer Valley Life Sciences Institute. Highly metastatic and tropic MDA-MB-
231 variants were kindly provided by Joan Massagué at the Memorial Sloan Kettering Cancer 
Center. These cell lines preferentially metastasize to the bone (1833 BoM [26]) brain (831 BrM2a 
[27]) or lung (4175 LM2 [28]). All cells were cultured in Dulbecco’s modified eagle medium 
(DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P/S) at 37°C and 
5% CO2. 
Synthesis of Poly(ethylene glycol)-phosphorylcholine (PEG-PC) Gels. PEG-PC gels were 
formed as previously described [29]. For this application, a 17wt% solution of 2-
methacryloyloxyethyl phosphorylcholine (PC) (730114-5g, Sigma Aldrich, St. Louis, MO) in pH 
7.4 phosphate buffered saline (PBS) was mixed with varying concentrations of poly(ethylene 
glycol) dimethacrylate (PEGDMA) (Sigma Aldrich). This solution was filtered through a 0.22 µm 
PVDF syringe filter, and excess oxygen was removed by degassing with nitrogen for 30 seconds. 
20wt% Irgacure 2959 (BASF, Florham Park, NJ) was dissolved in 70% ethanol and added to the 
polymer solution in a ratio of 40 µL Irgacure to 1 mL of polymer solution. 50 µL of this final 
hydrogel precursor solution was sandwiched between a 3-(trimethoxysilyl)propyl-methacrylate 
treated 15mm diameter coverslip and an untreated coverslip and UV polymerized for 20 minutes. 
Gels were swelled in PBS for at least 48 hours before functionalizing the surface using 0.3 
mg/mL Sulfo-SANPAH (c1111-100mg, ProteoChem, Hurricane, UT) in 50 mM HEPES buffer at 
pH 8.5, under UV for 10 minutes. Gels were then flipped onto droplets to achieve a theoretical 
maximum possible surface concentration of either 10 µg/cm² collagen 1 (A1048301, Thermo 
Fisher Scientific) (Fig. S1a-b), 10 µg/cm² collagen 1 + 0.5 µg/cm² β1-chain-containing laminin 
6 
 
isoforms (AG56P, Millipore, Billerica, MA) (Fig. S1c), or 10 µg/cm² collagen 1 + 20 ng/cm² EGF 
(R&D Systems, Minneapolis, MN) (Fig. S1d), binding via amines. These theoretical values are 
calculated based on the surface area of each hydrogel and amount of protein we supply for 
functionalization. Gels were incubated with protein overnight in a hydrated chamber at room 
temperature, washed in PBS, and sterilized under germicidal UV for 1 hour before cell seeding. 
For mechanical testing, gels were formed in a cylindrical mold (5µm high, 5µm diameter), 
allowed to swell for at least 48 hours and compression rheology was performed using an AR2000 
(TA Instruments, New Castle, DE), as previously described [29]. 
RNA-Seq. Total RNA was isolated using Gen Elute mammalian total RNA Miniprep kit 
(RTN70, Sigma Aldrich). The TruSeq stranded RNA LT kit (15032612, Illumina, San Diego, 
CA) was used to purify and fragment the mRNA, convert it to cDNA, and barcode and amplify 
the strands. Quality and length of the inserts was confirmed with an Agilent Genomics 2100 
bioanalyzer, followed by single-end 75 bp reads on the MiSeq (Illumina) to generate a complete 
transcriptome from each sample. Transcripts were aligned to the hg19 human reference genome 
using the Tuxedo Suite pathway [30-33]. Cufflinks was used to determine statistically significant 
differential expression of genes (p<0.05) [34-36].   
qRT-PCR. Total RNA was isolated from two biological replicates as previously described [37]. 
50 ng cDNA was then amplified using 10 pmol specific primers (Table S1) and the Maxima Sybr 
green master mix (Thermo Fisher Scientific) on a Rotor-Gene Q thermocycler (Qiagen, Valencia, 
CA) as follows:  50°C for 2 minutes, 95°C for 10 minutes followed by 45 cycles at 95°C for 10 
seconds, 58°C for 30 seconds, and 72°C for 30 seconds.  Both β-actin and ribosomal protein S13 
were included as reference genes to permit gene expression analysis using the 2-ddCt method.   
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Cell Adhesion Quantification. MDA-MB-231 cells were seeded at a final density of 5,700 
cells/cm2. Cells were either seeded immediately, or pretreated for 30 minutes before seeding with 
20 µM ERK inhibitor FR180204 (Sigma Aldrich), 10 µg/mL calpain inhibitor IV (208724, 
Millipore), 20 µM lapatinib (LC Laboratories, Woburn, MA), or 100 ng/mL EGF. The plate was 
pre-incubated on the Zeiss Axio Observer Z1 microscope (Carl Zeiss AG, Oberkochen, Germany) 
for 1 hour, then cells were seeded onto gels functionalized with 10 µg/cm² collagen 1, 10 µg/cm² 
collagen 1 + 0.5 µg/cm² laminin, or 10 µg/cm² collagen 1 + 20ng/cm2 bound EGF and imaging 
was started within 10 minutes of seeding. Images were taken with a 20x objective every 5 minutes 
for at least 2 hours. Cells were manually traced using Image J (NIH, Bethesda, MD). n ≥ 50 cells 
per condition. 
Cell Migration. Cells were seeded onto gels functionalized with 10 µg/cm² collagen 1 or 10 
µg/cm² collagen 1 + 20ng/cm² EGF at a density of 5,700 cells/cm2 and allowed to adhere for 24 
hours. For inhibitor conditions, cells were treated 2 hours prior to the start of imaging with 10 
µg/mL calpain inhibitor IV, 20 µM ERK inhibitor FR180204, 20 µM lapatinib, or 10 ng/mL EGF 
(R&D Systems). Cells were imaged at 15 minute intervals for 12 hours on the Zeiss Axio 
Observer Z1 microscope (Carl Zeiss AG). n≥ 48 cells per condition were quantified using the 
manual tracking plugin for Image J (NIH, Bethesda, MD).  
Generation of ITGA6 and CAPN2 shRNA transduced cells.  The shRNA sets specific to 
human ITGA6 (Sequence: CCGGCGGATCGAGTTTGAT 
AACGATCTCGAGATCGTTATCAAACTCGATCCGTTTTTG) and CAPN2 (sequence: 
CCGGCAGGAACTACCCGAACACATTCTCGAGAATGTGTTCGGGTAGTTCCTGTTTTT
G) were purchased from Sigma-Aldrich (St. Louis, MO).  Plasmids (in pLKO.1-puro) were 
packaged into virus particles according to manufacturer’s instructions and used to transduce 
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MDA-MB-231-luciferase cells.  Stable pools were selected using 1 mg/mL puromycin 
(Invivogen, San Diego, CA).  Cells transduced with a non-targeting shRNA served as a control. 
Immunofluorescent Staining and Imaging. 28,500 cells/cm2 were seeded and fixed at 24 
hours in 4% formaldehyde. Cells were permeabilized in Tris-Buffered Saline (TBS) with 0.5% 
Triton-X and washed 3 times in TBS with 0.1% Triton-X (TBS-T). Blocking was done for 1 hour 
at room temperature in TBS-T + 2%w/v Bovine serum albumin (BSA, Sigma Aldrich) (AbDil). 
Cells were then incubated in primary antibody in AbDil for 1 hour at room temperature using 1 or 
more of the following antibodies; vinculin (V9264-200UL, 1:200, Sigma Aldrich), pEGFR-
Y1068 (ab32430, 1:200, Abcam, Cambridge, MA), total EGFR (D38B1, 1:200, Cell Signaling, 
Danvers, MA), integrin α6 (ab134565, 1:200, Abcam), integrin α3 (ab131055, 1:200, Abcam), 
ERK (ab54230, 1:200, Abcam), calpain 2 (MABT505, 1:200, Millipore), or phalloidin 647 
(A22287, Thermo Fisher Scientific). For insoluble fractions, cells were permeabilized in cold 
Tris-Buffered Saline (TBS) with 0.5% Triton-X at 4°C for 1 minute prior to fixing. For 
immunofluorescent imaging of ECM proteins, cells were fixed at 24 hours (57,000 cells/cm2) or 6 
days (11,400 cells/cm2) before staining with a  pan-laminin antibody (ab11575, 1:100, Abcam), 
collagen 1 antibody (ab6308, 1:200, Abcam), or Fibronectin-488 antibody (563100, 1:200, BD 
Biosciences, San Jose, CA). Molecular Probes secondary antibodies were used at a 1:500 dilution 
(goat anti-mouse 555 (A21422) and goat anti-rabbit 647 (A21244) or goat anti-rabbit 488 
(A11008), Thermo Fisher Scientific). Cells were then treated with DAPI at a 1:5,000 dilution for 
5 minutes, and washed in PBS prior to imaging of 2 biological replicates on a Zeiss Cell Observer 
Spinning Disk (Carl Zeiss AG).  
Matrix Decellularization. Cells were cultured on PEG-PC gels of 1, 4, 8, and 41 kPa for 24 
hours or 6 days, and the resulting matrix created by the cells was visualized by adapting a 
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previously published protocol [38]. Briefly, cells were washed with warm PBS, then lysed with 
500µL warm extraction buffer (PBS with 0.5% Triton-X with 20 mM ammonium hydroxide) for 
10 minutes at room temperature. 1 mL of PBS was added and the gels were stored overnight at 
4°C before staining as described above.  
Protein and Phospho-protein Quantification. Autolyzed calpain 2 was analyzed via western 
blot. Cells were cultured on PEG-PC gels of 1 or 41 kPa for 24 hours, then lysed in RIPA buffer 
with protease inhibitors: 1 cOmplete Mini EDTA-free Protease inhibitor cocktail tablet per 10 
mL (Roche, Indianapolis, IN) 1 mM phenylmethylsulfonyl fluoride (Thermo Fisher Scientific), 5 
μg/mL pepstatin A (Thermo Fisher Scientific), 10 μg/mL of leupeptin (Thermo Fisher 
Scientific), and phosphatase inhibitors: Phosphatase inhibitors cocktail-II (Boston Bioproducts, 
Boston, MA), 1 mM sodium pyrophosphate (Thermo Fisher Scientific), 25 mM β-
glycerophosphate (Santa Cruz, Dallas, TX). Lysates were prepared in a 5x reducing sample 
buffer (39000, Thermo Fisher Scientific), run on Tris-Glycine gels in an Invitrogen mini-Xcell 
Surelock system, and then transferred to nitrocellulose membranes (88018, Life Technologies, 
CA). Membranes were blocked with AbDil for 1 hour, then stained overnight at 4°C with 
antibodies against calpain 2 (MABT505, 1:1000, Millipore), integrin α6 (ab134565, 1:2000, 
Abcam), EGFR (D38B1, 1:1000, Cell Signaling Technology, Danvers, MA), integrin α3 
(343802, 1:1000, Biolegend, San Diego, CA), integrin β4 (ab29042, 1:1000, Abcam), GAPDH 
(ab9485, 1:2000, Abcam) or β-actin (ab75186, 1:1000, Abcam). Membranes were washed 3 
times with TBS-T, stained in secondary antibody (Goat anti-rabbit 680 (926-68021, 1:20,000) 
and Donkey anti-mouse 800 (926-32212, 1:10,000), LiCor, Lincoln, NE) for 1 hour at room 
temperature, protected from light, and washed 3 times in TBS-T with a final wash in TBS. 
Membranes were imaged on the Odyssey CLx (Licor).  
10 
 
2 biological replicates of lysates were collected during cell adhesion at time 0, at 5 minutes, 
and at 24 hours. At 5 minutes, the adhered fraction was lysed off the surface, while suspended 
cells were pelleted, then lysis buffer was added. These 2 fractions were combined for analysis. 
Phospho-protein levels were quantified with the MAGPIX system (Luminex, Austin, Texas) 
with MILLIPLEX MAP Multi-Pathway Magnetic Bead 9-Plex - Cell Signaling Multiplex Assay 
(48-681MAG, Millipore) and added beads against p-EGFR (pan-tyrosine, 46-603MAG, 
Millipore), p-MEK (Ser222, 46-670MAG, Millipore), and p-ERK1/2 (Thr185/Tyr187, 46-
602MAG, Millipore), following the manufacturer’s protocols, with beads and antibodies used at 
0.25x.  
Co-Immunoprecipitation. MDA-MB-231 cells were grown to confluence in a T-75 cell 
culture flask. Cells were treated with 10 mL of fresh media containing 10% FBS, with or without 
an additional 100 ng/mL EGF for 10 minutes. Flasks were lysed in 4.5 mL of lysis buffer, 
comprised of 50 mM Tris (pH 7.4), 0.15 M NaCl, 0.1% Triton-X, with protease and phosphatase 
inhibitors as described above. 1 mL of lysate was immunoprecipitated with 10 µL agarose beads 
(Thermo Fisher Scientific) with either 5 µL rabbit IgG (ab6718, Abcam), 10 µL anti-EGFR 
(D38B1, Cell Signaling), or with 10 µL anti-EGFR pre-conjugated to sepharose beads (5735S, 
Cell Signaling). Lysates were precipitated on beads overnight at 4°C on a rotating platform and 
spun down. Beads (with protein) were washed 3x with TBS, and boiled in 70 µL of DiH2O and 
sample buffer. Blotting was done as described above for pEGFR (ab32430, Abcam) and integrin 
α6 (ab134565, Abcam).  
Statistical Analysis. One-way Analysis of Variance (ANOVA) with a Tukey post-test was 
performed on paired samples using Prism v5.04  (Graphpad software, La Jolla, CA). Data 
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reported is the mean and reported error is standard deviation with significance values of p ≤ 0.05 
as *, p ≤ 0.01 as **, and p ≤ 0.001 as ***. 
 
Results 
Cells Maximize Expression of Integrin α6 and Extracellular Laminin on Soft Substrates 
To identify ECM and integrin-associated genes involved in breast cancer mechanosensing, 
we performed whole transcriptome sequencing (RNA-Seq) on MDA-MB-231 cells cultured on 
collagen 1-functionalized PEG-PC hydrogels ranging in stiffness from 1 to 41 kPa for either 24 
hours or 6 days (Fig. S2a). The tumor microenvironment is rich in collagen, which provides 
structural and biochemical signals to tumor cells to facilitate migration and metastasis [39]. 
Further, The stiffness range chosen spans that of several tissues in the body where breast cancer 
metastasizes (1 kPa- brain [40], 4 kPa- bone marrow [41], 8 kPa- lung [42]), as well as a supra-
physiological stiffness (41 kPa) that approximates extremely stiff breast tumors [43] and a tissue 
culture polystyrene (TCPS) control (Fig. S2). 
Because the ECM is known to regulate the ability of cancer cells to migrate and metastasize, 
we focused our in-depth analysis of this RNA-Seq data set on genes that regulate interaction with 
the ECM. We found that the expression of integrins, other focal adhesion complex genes, and 
genes downstream of EGFR phosphorylation became sensitive to stiffness over time (Fig. 1a-b, 
Fig. S2b). Short-term (24 hour) decreases in expression were clear in integrin α6, calpain 2, and 
integrin β4 (Fig. 1a). However, integrin β4 expression was 3-fold higher on gels than on TCPS 
after 6 days of culture (Fig. 1b), which we confirmed at the protein level (Fig. S3a). This implies 
a switch in dimer pairs, as integrin α6 preferentially dimerizes with integrin β4 over integrin β1 
[44]. This is an important finding, as α6β4 is known to be important in cancer cell motility and 
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invasion [45]. We compared the day 6 gene expression data from Figure 1b to that at 24 hours 
from Figure 1a and found that the expression of this subset of genes was generally higher at day 6 
(Fig. S2b), suggesting a time-dependent mechanosensing event related to this set of integrins, 
focal adhesion proteins, and EGFR. 
Given that integrin α6β4 is laminin-binding, and that we saw mechanosensitive changes in α6 
gene and protein expression (Fig. S3b), we hypothesized that we could tune integrin α6 
mechanosensing on these surfaces by supplementing the collagen-functionalized hydrogel 
surfaces with β1-chain-containing laminins. On soft gels, integrin α6 expression was higher at 24 
hours with added laminin compared to collagen 1 only, and it was also high after 6 days of 
culture, even in the absence of supplemented laminin (Fig. 1c, Fig. S3c). This mechanosensitivity 
appears to be specific to integrin α6 as other laminin-binding integrins (e.g. integrin α3) did not 
follow this trend (Fig. S3d-e).  
As we noted this integrin α6 effect when we supplied only collagen 1, we hypothesized that 
cells might be producing their own laminin to support integrin α6 binding at the longer culture 
times. Immunofluorescent staining revealed that laminin, but not collagen 1 (Fig. 1d) or 
fibronectin (Fig. S4a), was upregulated on the softer gels at 6 days. We separately confirmed that 
differential staining was not due to ECM proteins crosslinked to the gels or from serum (Fig. 
S4b). Cultures that were decellularized after 6 days showed the highest amount of extracellular 
laminin on the softest, 1 kPa gels (Fig. 1d), concordant with the increase in integrin α6 expression 
in Figure 1c.  
To understand the impact of laminin and integrin α6 expression on cell phenotype, we 
quantified cell spreading during initial adhesion to the hydrogel surfaces.  We found cells spread 
to similar extents across the 4 stiffnesses examined here when only collagen 1 was present (Fig. 
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1e). However, when laminin (0.5µg/cm2) was added to the collagen (10µg/cm2) on the gel 
surfaces, cell spreading was mechanosensitive (Fig. 1f). We attempted to remove collagen from 
the experiment completely, but found that cells did not adhere to laminin-only hydrogels (data not 
shown). This was not surprising given the documented role of laminin being somewhat anti-
adhesive [46]. In sum, cells upregulate integrin α6 expression on soft substrates, which correlates 
with secretion of extracellular laminin. This coordination appears to take several days, but the 
mechanosensitivity effect on cell spreading can be accelerated by adding β1-chain-containing 
laminin to the culture substrata.  
 
Cell Response to EGF Stimulation Mirrors Mechanosensing on Laminin 
Given the prevalence of EGF in the tumor microenvironment and its known role in 
promoting cancer cell motility, we posited that the mechanosensitive expression of EGFR 
alongside the laminin-binding integrin α6 implied that they mechanotransduce under a related 
pathway. Similar to previous reports, we found that MDA-MB-231 cells spread to a smaller area 
on hydrogels upon addition of EGF prior to and during adhesion [37], achieving a similar size to 
cells on soft, laminin-coated gels without EGF (Fig. 2a). EGFR is known to associate with the 
α6β4 integrin heterodimer to enhance clustering and response to EGF [47], and in agreement with 
this report, we found that the addition of EGF increased the association of integrin α6 with EGFR 
in our system (Fig. S5a). We separately analyzed the protein expression of integrin α6 and EGFR 
in variants of the MDA-MB-231 cell line selected for their ability to metastasize specifically to 
the brain, bone, and lung [26-28].  The brain tropic cells, which metastasize to the softest of these 
sites, have the highest expression of both integrin α6 and EGFR (Fig. S5b).  
14 
 
To test the necessity of integrin α6 in the observed response to EGF, we generated a stable 
shRNA knockdown cell line (shITGA6, Fig. S5c-e). We quantified adhesion of the shITGA6 cells 
to collagen-functionalized gels, and found that they spread to a larger area during adhesion with 
EGF stimulation, compared to cells transfected with the scramble control (shSCR), suggesting a 
role for integrin α6 during EGF response on collagen (Fig. 2b). Even though there was no laminin 
present, others have demonstrated a role for integrin α6 in facilitating growth factor response, 
independent of laminin binding [48]. Combined with our data, this implicates a mechanosensitive 
role for integrin α6 during EGFR signaling (Fig 2b). 
 
EGF Overwhelms Laminin-Based Mechanosensing and Maximizes Cell Motility on Soft 
Substrates  
To further explore the relationship between integrin α6 and EGFR signaling during 
adhesion, we functionalized hydrogels with collagen 1 and laminin, and treated the cells with 
lapatinib, a dual tyrosine kinase inhibitor against EGFR and HER2. This approach allowed cells 
to engage integrin α6 during adhesion, while preventing EGFR signaling by obstructing ATP-
binding on the intracellular domain of EGFR and HER2. When pretreated with lapatinib, we 
found that cells adhering on 41 kPa hydrogels spread to a significantly larger area than cells on 1 
kPa hydrogels (Fig. 2c). This result mimics the adhesion we observed of cells on laminin without 
supplemented EGF or lapatinib (Fig. 1f). Further, when we supplemented cells with soluble EGF 
on the surfaces functionalized with collagen 1 and laminin, cells on both 1 and 41 kPa spread to a 
smaller area (Fig. 2d). This EGF-induced reduction in spreading is similar to our observations of 
cells on collagen 1 only in the presence of soluble EGF (Fig. 2a). Together, these data suggest 
that, even in the presence of laminin, adhesion signaling through EGFR dominates, but in the 
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absence of exogenous EGF, signaling via mechanosensitive integrin α6 controls cell spreading 
during adhesion. 
We observed that sEGF caused rapid internalization of EGFR, within 10 minutes of 
administration (Fig. S5f). To promote sustained EGFR signaling to examine its relationship with 
integrin α6 [47], we covalently linked both collagen 1 and EGF to the surface of the hydrogels. 
This EGF presentation minimized EGFR internalization (Fig. S5f) and localized both 
pEGFR(Y1068) and total EGFR to regions of vinculin staining (Fig. 2e, Fig. S6a). EGFR receptor 
internalization was required for EGF to moderate adhesion, as only cells supplemented with 
soluble EGF showed measurable differences in cell area after 40 minutes (Fig. 2f). However, 
bound EGF had a measurable effect on cell motility (Fig. 2g). First, we observed a biphasic trend 
in cell speed with respect to stiffness. This phenomenon has previously been described in many 
cell types, including smooth muscle cells [7] and glioma cells in both 2D [49] and 3D [50]. In this 
migration study, only collagen 1 was present, suggesting that collagen-binding integrins 
contributed to this mechanosensitive motility after 24 hours [51]. Our data agree with literature 
reports demonstrating that cells seeded on collagen 1 exhibit mechanosensitive motility [52], but 
do not differ in adherent area between 1 and 30 kPa [53]. The addition of bound EGF increased 
cell motility across the stiffness range tested here (Fig. 2g), and shifted the biphasic curve to 
softer substrates, requiring us to expand the mechanical range of the hydrogels to capture the full 
curve (Fig. S6b) [29]. We also observed a role for integrin α6 in regulating this EGF-dependent 
motility, as shITGA6 cells were less responsive to EGF than the control (Fig. 2g). The scramble 
control cells, which peaked at 34 µm/hr on 1 kPa gels, were more responsive to EGF than the 
shITGA6 cells (Fig. S6c). Interestingly, shITGA6 cells don’t respond to changes in stiffness from 
1 to 18 kPa, either in control media, or in response to soluble EGF (Fig. S6d). Together, this data 
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suggests that the addition of EGF alters mechanosensitive motility and that the MDA-MB-231 
breast cancer cells are dependent on integrin α6 for this response.    
 
Calpain 2 is Downstream of both EGFR and Integrin α6 Mechanosensing 
Inspired by the trends observed in the RNA-seq data (Fig. S2), we clustered our PCR data 
from the 24 hour time point, which uncovered that ITGA6 and EGFR expression clustered with 
the intracellular protease CAPN2 (Fig. 3a). Calpain 2, which has been implicated in focal 
adhesion formation and disassembly, is thought to play an important role in breast cancer cell 
motility and metastasis [54]. Because calpain 2 is activated by ERK [55], we performed phospho-
analysis of multiple kinases in integrin- and EGFR-dependent pathways (Fig. S7a). Steady-state 
phosphorylation of EGFR, MEK, and ERK increased on stiffer surfaces, as previously 
demonstrated [20, 56, 57] (Fig. S7b). However, we observed the opposite trend with the 
activation of calpain 2 (Fig. S7c).  
We observed higher calpain 2 activity (autolysis) during adhesion to the soft hydrogels 
compared to tissue culture plastic (Fig. 3b). Although repeated multiple times, this trend was not 
statistically significant. There was a functional role for calpain 2 during mechanosensing on the 
gels, however, as a pharmacological inhibitor to either calpain 2 or ERK had no effect on cell 
spreading on 1 kPa gels, but resulted in significantly larger cells on 41 kPa gels (Fig. 3c-d). In 
parallel, to provide evidence of the necessity of calpain 2 in responding to EGF stimulation, we 
generated a CAPN2 knockdown cell line (Fig. S8a-c), and observed that those cells were less 
responsive to EGF than the scramble control cells during adhesion, independent of stiffness (Fig. 
S8d). Further, calpain 2 inhibition was sufficient to limit cell response to soluble EGF using a 
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pharmacological inhibitor (Fig. S8e). However, when we limited calpain 2 activity in integrin α6 
knockdown cells, the effect of larger cells during adhesion was exaggerated (Fig. S8e).  
We further hypothesized that altering calpain 2 activity could disturb the typical biphasic 
relationship between cell migration speed and matrix stiffness given its known role in mediating 
focal adhesion turnover [55]. Inhibiting ERK activity entirely eliminated the durokinesis effect, 
and calpain 2 inhibition shifted the migration curve maximum to lower stiffnesses (Fig. 3e). The 
limiting step during motility on stiff surfaces is retraction of the rear edge [58], and here we 
demonstrate that inhibiting calpain 2 reduces cell migration on stiffer substrates, likely because of 
this reduced ability to turn over adhesions. We then compared migration speeds of the integrin α6 
knockdown and scramble control cells from figure 2, in response to the calpain 2 inhibitor (Fig. 
S6d). We found that the scramble control cells responded to the inhibitor similarly to the parental 
cells, although the addition of soluble EGF was able to partially overcome that inhibition. 
However, the shITGA6 cells exhibited slower migration at 18 kPa even in the control media, so 
the calpain 2 inhibitor had no additional effect (Fig. S6d). 
After 24 hours of culture on PEG-PC gels with collagen 1 or collagen 1 and bound EGF, 
cells adopted a normal morphology with no noticeable protrusions (Fig. S8f). However, in the 
presence of lapatinib, ERK inhibitor, or calpain 2 inhibitor, we observed that cells left behind 
long, stable protrusions at the rear of the cell (Fig. S8f), indicative of their inability to release 
adhesion sites [59]. There were minimal observable differences in morphology as a function of 
stiffness, regardless of the pharmacological treatment applied. This suggests that at these 
concentrations, the inhibitors impact focal adhesion turnover enough to functionally alter motility 
with marginal impacts on morphology at these stiffnesses.  
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While we demonstrated earlier that integrin α6 is necessary for both mechanosensitive and 
EGFR-mediated adhesion, this data suggests that EGFR activates calpain 2 to regulate 
mechanosensitive motility in breast cancer cells. To some extent on collagen-functionalized 
hydrogels, and particularly on plastic, calpain 2 activity was low, and EGF stimulation increased 
calpain 2 activity on the hydrogels (Fig. 3f). Finally, when we supplemented the gels with 
laminin, calpain 2 activity was maximized on both stiffness gels, suggesting an additional role for 
integrin α6 engagement to activate calpain 2. Interestingly, when integrin α6 is knocked down in a 
stable manner, the cells still exhibit calpain 2 activity, suggesting that the cells might be 
compensating for the lack of integrin α6 signaling via another mechanism, not explored here (Fig. 
S8g). Together, these data suggest that the mechanosensitive receptors integrin α6 and EGFR both 
activate calpain 2 to facilitate stiffness-dependent adhesion and migration.   
 
Discussion 
This work demonstrates integrin α6 and calpain 2 as mechanosensitive proteins important 
for stiffness-driven breast cancer cell adhesion and migration (Fig. 4a). The mechanosensitivity of 
calpain 2 is a new finding, as well as the role of integrin α6 in EGFR signaling that facilitates cell 
adhesion (Fig. 4b). EGF is known to enhance breast cancer cell adhesion and motility, and here 
we demonstrate that mechanosensitive integrin α6 and EGFR both signal through calpain 2.  We 
also contribute that in the absence of EGF stimulation, integrin α6 and calpain 2 regulate stiffness-
dependent adhesion and motility (Fig. 4b).  
We focused this study on breast cancer cells because of the important roles for ECM 
binding and stiffness in metastasis. Cancer metastasis begins with individual or collective groups 
of cells migrating away from the primary tumor site [60-62]. This motility is driven in part by 
19 
 
cell-ECM adhesion via integrins and the creation and turnover of focal adhesions, both of which 
are known to be sensitive to the stiffness of the surrounding ECM [63]. Integrins have well 
documented responses to changes in the microenvironment stiffness. As two examples, the 
expression of integrins α2, α3, and β1 is higher in mouse mammary epithelial cells cultured on 
TCPS compared to cells on a soft basement membrane-like matrix [51], and integrin α5 
expression was found to increase 5-fold on a 10 kPa stiffness compared to 1 kPa in cancer cells 
[17] and over a similar range in fibroblasts [64]. Most of this work has focused on collagen- and 
fibronectin-binding integrins, with the exception of one paper on integrin α6 in fibroblasts, where 
expression increased with stiffness, resulting in increased invasion [65]. We demonstrate here the 
mechanosensitivity of integrin α6 in breast cancer cells, and the downstream regulation of cell 
adhesion, migration, and response to EGF (Fig. 1c, Fig. 2b). Integrin α6 is a laminin-binding 
subunit, and so many of the stiffness-sensitive phenotypes we observed either required, or were 
exaggerated by, addition of laminin to the culture substrate. However, cells exhibited 
mechanosensitive behavior on collagen alone when cells were on hydrogels for longer times. For 
example, we observed a biphasic relationship in migration speeds on collagen 1 only (Fig. 3e). 
We present data that on soft surfaces, cells produce extracellular laminin and engage integrin α6 in 
these instances, and that knocking down integrin α6 expression limited response to EGF (Fig. 2g).  
Previous work has established the role of integrin α6 in key aspects of the metastatic 
cascade. Low integrin α6 expression inhibits the migration and proliferation necessary for 
establishing metastases at distant secondary sites [66]. Additionally, integrin α6 expression can 
protect cells from radiotherapy treatment both through PI3K and MAPK activity [67]. In a cohort 
of 80 patients, integrin β4 was co-expressed with integrin α6 and laminin in primary tumors, and 
co-expression of α6β4 with laminin production was significantly correlated with breast cancer 
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relapse and death [44, 68]. This is further supported by other work in breast cancer, that elucidates 
the role of laminin-511 in cell adhesion and migration [18], which are key phenomena in the 
metastatic cascade. Our data demonstrate that this is a mechanoresponsive effect, as the most 
laminin is secreted by the breast cancer cells on the softest substrate (Fig. 1d). Interestingly, this 
phenomenon is not maintained in other secreted ECM proteins, such as collagen 1 (Fig. 1d) or 
fibronectin (Fig. S4a), suggesting a key role for integrin α6 binding to laminin on soft surfaces. 
This is possibly mediated through the mechanically responsive transcription factor, TAZ [69], 
which has been shown to regulate laminin production [70]. Here we found that both integrin β4 
expression and laminin production increased after 6 days of culture on soft gels (Fig. 1b, Fig. 1d), 
where EGF enhances migration in an integrin α6-dependent manner (Fig. 2g). 
We further observed that during cell adhesion, integrin α6 engagement with laminin 
decreased cell size and facilitated adhesion similarly to EGF (Fig. 2a-b). Smaller cells can be 
correlated with a cancer stem cell and invasive phenotype [71], and our work suggests integrin-
mediated mechanotransduction contributes to that behavior. The α6β4 integrin dimer associates 
with EGFR [47], and we observed that integrin α6 engagement increased the sensitivity to EGF 
(Fig. 2b). Further, our data agrees with other work, which has demonstrated that the integrin 
dimer α6β4 plays an important role in cell response to growth factors, even in the absence of 
laminin [48]. We also observed that integrin α6 adhesion shows a similar phenotypic response on 
soft hydrogels as EGF stimulation.  
Downstream of integrin α6 engagement and EGFR phosphorylation, cells activate calpain 2, 
which facilitates focal adhesion turnover, and therefore, motility (Fig. 3e-f). EGFR 
phosphorylation is necessary for mechanosensing [21] and activity in downstream effectors, 
including MEK, ERK, and calpain 2 at the cell membrane [72, 73], to cleave focal adhesion 
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proteins vinculin, talin, paxillin, and FAK [74, 75]. Additionally, recent work has demonstrated 
that calpains are recruited to protrusions containing integrin β4 [76]. During adhesion, we saw that 
calpain 2 activity was higher in cells on the hydrogels compared to TCPS, which was consistent 
with RNA levels (Fig. 1a-b, Fig. S7c). Calpain 2 inhibition during adhesion resulted in larger, less 
motile cells on stiff substrates. The opposite trend in adhesion was observed when activating this 
pathway, as cells spread to a smaller area at both 1 and 41 kPa in the presence of soluble EGF 
(Fig. 2a). Together, these data suggest that EGFR phosphorylation could be a stronger activator of 
calpain 2 than stiffness. Previous work has shown that calpain 2 has a significant correlation with 
an epithelial-to-mesenchymal transition [77] and lymphatic or vascular invasion, where patients 
with basal-like tumors and high calpain 2 expression had a significantly worse prognosis [78]. 
Others have also found that this is an isoform-specific effect, as calpain 2, but not calpain 1, was 
upregulated in gastric cancer compared to healthy tissue [79]. Our work demonstrates a 
mechanosensitive role for calpain 2, downstream of both integrin α6 and EGF, providing further 
evidence for its potential as a druggable target for metastatic breast cancer.   
 
Conclusions 
Mechanical forces have long been thought to play a role in tumor progression, and here we 
shed new light on two mechanoresponsive proteins that influence breast cancer cell motility: 
integrin α6 and calpain 2. First, enhanced integrin α6 expression on soft substrates is associated 
with increased adhesion and laminin secretion. Second, we find that both integrin α6 and EGFR 
activate calpain 2 in a mechanosensitive manner, which mediates cleavage of focal adhesion 
proteins necessary for motility. Others have suggested targeting calpains to inhibit cancer cell 
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invasion [80], and here we provide a mechanosensitive role of calpain 2 using tunable hydrogel 
substrates.  
 
 
 
Author Contributions 
ADS, SRP, and CCB participated in experimental design. ADS, CLH, and LEB performed 
experiments. All authors discussed results and contributed to editing of the manuscript.  
 
Conflict of Interest 
The authors declare no conflict of interest. 
 
 
